About Us
At A Glance
Business Overview
Timeline And History
Global Operations Map
Business Units
API
Antiretroviral (ARV)
Overview
Key facts about HIV/AIDS
Products
Global Partners
Gallery
Corporate Video
AuroZymes
Custom Synthesis
Formulations
Peptides
R&D
Corporate Governance
Board Of Directors
Board Committees
Sustainability
ESG / Sustainability
ESG Profile
Sustainability Reports
BMW Reports
Social-Accountability-Standards
Social Compliance Certification
Sustainability Of Social Accountability Standards
Human Rights Policy
Progressive Health And Safety Practices
Community Impact
Supply Chain Management
Supplier Code of Conduct
CSR
Our Commitment
Annual Report
Gallery
Aurobindo Pharma Foundation
Annual Action Plan
Impact Assessment Reports - CSR Projects
Access To Healthcare
Pepfar program
Investors
Results, Reports & Presentations
Results Announcements
Annual Reports
Financials - Subsidiaries
Related Party Transactions
Shareholder Information
Shareholding Pattern
Buyback of shares
Share Performance
Financial Highlights
Notice Of Board Meeting
General Meetings
Dividend Record
Scheme Of Arrangements
Unpaid Dividend Account Details
Registrar And Share Transfer Agent
Contact Details For Investor Grievance Redressal
General
Corporate Governance
Board Of Directors
Board Committees
Governance Policies
Code Of Conduct
Code Of Practices And Procedures For Fair Disclosure
Appointment And Resignation Of Directors
Contact Details Of KMPs
IR Contacts
Disclosures Under Regulation 46
Disclosures under Regulation 46 of the LODR
Media
Press Releases
Corporate Announcements
Media Kit
Fact Sheet
Videos
Official Logos
Careers
HR Mission And Vision
Current Vacancies
Searchable Database
Contact Us
DELIVERING ROBUST FINANCIALS
We believe that execution is everything
and always challenge ourselves to deliver superior performance
home
investors
results reports presentations
investor presentations
Investor Presentations
2023 - 2024
2022 - 2023
2021 - 2022
2020 - 2021
2019 - 2020
2018 - 2019
2017 - 2018
2016 - 2017
2015-2016
Investor Presentation - 2023 - 2024
Investor Presentation – March 2024
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
I Accept
Cookie policy